Over the last 7 days, the Clinical Research and Equipment industry has dropped 15%, driven by Divi's Laboratories declining 18%. In contrast, Tarsons Products has gained 6.2%. Overall the industry is down 14% in 12 months. Looking forward, earnings are forecast to grow by 7.2% annually.
Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE |
---|---|---|---|---|
Sun, 29 May 2022 | ₹1.2t | ₹158.0b | ₹34.0b | 31.5x |
Tue, 26 Apr 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 35.6x |
Thu, 24 Mar 2022 | ₹1.6t | ₹148.3b | ₹29.4b | 34.9x |
Sat, 19 Feb 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 36.8x |
Mon, 17 Jan 2022 | ₹1.6t | ₹137.8b | ₹24.6b | 40.5x |
Wed, 15 Dec 2021 | ₹1.6t | ₹137.8b | ₹24.6b | 32.4x |
Fri, 12 Nov 2021 | ₹1.6t | ₹134.6b | ₹23.6b | 23.9x |
Sun, 10 Oct 2021 | ₹1.7t | ₹131.1b | ₹22.9b | 22.9x |
Tue, 07 Sep 2021 | ₹1.7t | ₹131.1b | ₹22.9b | 25.3x |
Thu, 05 Aug 2021 | ₹1.6t | ₹127.1b | ₹22.6b | 39.6x |
Sun, 09 May 2021 | ₹1.4t | ₹121.4b | ₹21.5b | 40.3x |
Wed, 10 Feb 2021 | ₹1.2t | ₹116.0b | ₹22.4b | 38.3x |
Tue, 03 Nov 2020 | ₹1.1t | ₹114.7b | ₹22.2b | 28.5x |
Fri, 07 Aug 2020 | ₹929.8b | ₹116.1b | ₹19.8b | 46x |
Thu, 30 Apr 2020 | ₹771.1b | ₹116.7b | ₹17.2b | 28.4x |
Sun, 02 Feb 2020 | ₹664.2b | ₹101.6b | ₹18.5b | 31.7x |
Wed, 06 Nov 2019 | ₹657.8b | ₹104.8b | ₹20.4b | 24.6x |
Sat, 10 Aug 2019 | ₹620.8b | ₹101.2b | ₹19.9b | 31.9x |
31.2x
How does Indian Clinical Research and Equipment compare with similar industries?
IN Market | -0.87% | |
Healthcare | -1.99% | |
Life Sciences | -15.25% | |
Clinical Research and Equipment | -15.25% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
TARSONS Tarsons Products | ₹690.10 | 6.2% +₹2.1b | n/a | PS36.5x | |
538837 Jeevan Scientific Technology | ₹83.05 | 3.7% +₹45.1m | -10.9% | PS8.4x | |
533543 Brooks Laboratories | ₹83.60 | 2.2% +₹44.5m | -18.8% | PS2.7x | |
539267 Dr Habeebullah Life Sciences | ₹26.00 | 2.4% +₹8.9m | -20.1% | PB3.5x |